Reactive oxygen species are involved in many cellular metabolic and signalling processes 1 and are thought to have a role in disease, particularly in carcinogenesis and ageing 2 . We have generated mice with targeted inactivation of Prdx1, a member of the peroxiredoxin family of antioxidant enzymes 3 . Here we show that mice lacking Prdx1 are viable and fertile but have a shortened lifespan owing to the development beginning at about 9 months of severe haemolytic anaemia and several malignant cancers, both of which are also observed at increased frequency in heterozygotes. The haemolytic anaemia is characterized by an increase in erythrocyte reactive oxygen species, leading to protein oxidation, haemoglobin instability, Heinz body formation and decreased erythrocyte lifespan. The malignancies include lymphomas, sarcomas and carcinomas, and are frequently associated with loss of Prdx1 expression in heterozygotes, which suggests that this protein functions as a tumour suppressor. Prdx1-deficient fibroblasts show decreased proliferation and increased sensitivity to oxidative DNA damage, whereas Prdx1-null mice have abnormalities in numbers, phenotype and function of natural killer cells. Our results implicate Prdx1 as an important defence against oxidants in ageing mice.
Cellular defences against reactive oxygen species (ROS) include enzymes such as superoxide dismutase (which converts superoxide to hydrogen peroxide), catalase and glutathione peroxidase (which convert hydrogen peroxide to water), as well as non-enzymatic scavengers such as glutathione, ascorbic acid and carotenoids. Peroxiredoxins (Prdxs), a family of small antioxidant proteins that contain essential catalytic cysteine residues and use thioredoxin as an electron donor 3 , also scavenge peroxide and are thought to be involved in the cellular response to ROS. Prdxs are abundant proteins found in organisms from all three kingdoms, with at least five distinct members in mammals. Mammalian Prdx1, also known as Pag 4 4 and oxidative stress 5, 8 . Transfection studies show that Prdx1 can eliminate peroxide in vivo and can regulate ROS induced by growth factor signalling 9 . In addition to its role as an antioxidant enzyme, Prdx1 has been independently isolated as an erythrocyte cytosolic protein that enhances the cytoxicity of natural killer (NK) cells 10 , a letters to nature cytosolic protein from hepatocytes with high affinity for haem 11 , and a cytosolic and nuclear protein that functions as a stoichiometric inhibitor of the non-receptor tyrosine kinase c-Abl 12 . To determine the biological roles of Prdx1, we inactivated the Prdx1 gene by homologous recombination in murine embryonic stem (ES) cells (Supplementary Fig. 1 ) and generated heterozygous Prdx1
mice. In crosses of Prdx1 þ/2 mice, Prdx1 2/2 mice were born at the expected mendelian frequency (Fig. 1a and data not shown), lacked Prdx1 messenger RNA (Fig. 1b) , and showed normal postnatal development and fertility. However, prolonged observation of cohorts of wild-type, Prdx1 2/2 and Prdx1 þ/2 littermates showed a significantly shortened survival of Prdx1 2/2 mice relative to wild-type littermates (Fig. 1c) . Clinicopathological analysis suggested that there were two main causes of premature death in ageing Prdx1 2/2 mice: haemolytic anaemia, which first appeared at 9 months; and malignant tumours. Both diseases were also observed at increased frequency in Prdx1 þ/2 mice, beginning at around 12 months, whereas no wildtype mice developed haemolytic anaemia (Fig. 1c, inset ).
Many premorbid Prdx1
2/2 mice had severe anaemia characterized by a marked decrease in haematocrit and haemoglobin in peripheral blood relative to wild-type littermate controls, with normal leukocyte and platelet counts (Table 1) . Peripheral blood smears from these mice showed prominent microcytosis, anisocytosis, poikilocytosis and polychromatophilia of erythrocytes (Fig. 2a, b) , which coincided with an increase in both the width of the erythrocyte volume distribution (Table 1 ) and the numbers of reticulocytes (Fig. 2c and Table 1 ). At autopsy, anaemic mice frequently had splenomegaly (Table 1) , sometimes massive, owing to extramedullary erythropoiesis (Fig. 2d) . These findings are suggestive of anaemia due to decreased survival, rather than impaired production, of erythrocytes. In agreement with this, anaemic mice had increased blood lactate dehydrogenase and decreased haptoglobin ( Table 1) , indicative of the intravascular destruction of red cells. Similar clinicopathological features were observed in Prdx1 þ/2 mice (data not shown), which also developed severe anaemia with age (Fig. 1d) .
Serial analysis of blood haemoglobin in the Prdx1 2/2 mice showed a general and gradual decline, which began at around 12 months without any change in reticulocyte numbers (Fig. 2e) , similar to wildtype mice (data not shown). However, many ageing Prdx1 2/2 mice showed precipitous drops in blood haemoglobin over an interval of 1-2 months, coincident with and in some mice preceded by an increase in circulating reticulocytes. These data suggest that a subset of Prdx1 2/2 mice develop haemolytic anaemia as they age. To investigate the cause of the anaemia, we compared the survival of biotin-labelled erythrocytes obtained from anaemic Prdx1 2/2 mice against those from healthy wild-type littermates on transfer into wild-type recipients (Fig. 2f) . Whereas the rate of disappearance of labelled wild-type erythrocytes was roughly linear, with a loss of about 2% per day, Prdx1 2/2 erythrocytes disappeared at an exponential rate, indicative of an increase in elimination in vivo that was independent of red cell age. These results show that the anaemia letters to nature in ageing Prdx1 2/2 mice is due to shortened erythrocyte survival owing to an intrinsic defect in red cells.
The presence of Heinz bodies, representing precipitated haemoglobin, in Prdx1 2/2 erythrocytes (Fig. 2c, inset) suggested that the cause of red cell destruction might be increased erythrocyte ROS, leading to the oxidation of red cell proteins including haemoglobin. In support of this, we observed an increase both in baseline ROS and in ROS generated in response to hydrogen peroxide challenge in erythrocytes from anaemic Prdx1 2/2 and Prdx1 þ/2 mice but not in those from age-matched healthy Prdx1 mutant or wild-type mice (Fig. 2g) . Analysis of the carbonyl groups in cellular proteins, a by-product of oxidation, confirmed the increased oxidation of polypeptides in erythrocytes and bone marrow cells of anaemic Prdx1 mutant mice (Fig. 2h) . Finally, we confirmed the presence of oxidized, unstable haemoglobin in erythrocytes from anaemic Prdx1 2/2 mice by showing the increased sensitivity of free haemoglobin in red cell lysates to precipitation by isopropanol (mean precipitated haemoglobin, 33.5^4.3% for Prdx1 2/2 erythrocytes versus 2.1^2.0% for wild type; P , 0.01, unpaired t-test). Collectively, these results show that ageing Prdx1 mutant mice develop fatal haemolytic anaemia owing to an increase in erythrocyte ROS, oxidation and precipitation of haemoglobin, and haemolysis.
Cancer was a second main cause of morbidity and death in ageing Prdx1 mutant mice. Only 3 of 34 wild-type mice died with evidence of malignancy: two from disseminated histiocytic tumours and one from B-cell lymphoma. Both of these cancers are typically found in ageing B6, 129SvEv mice. By contrast, half (32/64) of the Prdx1 2/2 mice succumbed to malignancy either alone or in combination with haemolytic anaemia (Fig. 1d) . In addition to B and T lymphomas and histiocytic malignancy, the spectrum of cancers that developed in Prdx1 mutant mice included epithelial and mesenchymal tumours (hepatocellular carcinoma, fibrosarcoma, osteosarcoma, islet cell adenomas and adenocarcinomas of lung and breast), which are less common in ageing B6, 129SvEv mice ( Fig. 3a and Supplementary Fig. 2) .
Most sarcomas and lymphomas could be transplanted into nude or sublethally irradiated (275 cGy) severe combined immunodeficient (SCID) mice with latencies of around 1 month or 6 months, respectively (data not shown). An increase in the incidence of malignancy was also observed in Prdx1 þ/2 mice (Figs 1d and 3a) , although this was not associated with a decrease in overall survival. It is likely that some mice in this cohort had malignancy as a co-morbid condition but died of other causes such as infection. Although the expression of Prdx1 protein was abundant in many normal mouse tissues (Fig. 3b) , it was low to undetectable in lysates from several different tumours isolated from Prdx1 þ/2 mice (Fig. 3c) . This is reminiscent of the inactivation of a tumour suppressor gene and suggests that loss of Prdx1 function may contribute to tumorigenesis. We did not observe any gross structural rearrangements or loss of the wild-type Prdx1 allele in any tumours from Prdx1 þ/2 mice (data not shown), suggesting that either subtle mutations or epigenetic mechanisms such as methylation might be responsible.
To investigate possible mechanisms of tumorigenesis, we characterized murine embryonic fibroblasts (MEFs) derived from Prdx1 2/ 2 and wild-type littermates. Prdx1 2/2 MEFs proliferated more slowly and had a higher fraction of cells in the G1 phase of the cell cycle than did wild-type MEFs (Fig. 3d) . A role for Prdx1 in the cell cycle has been previously suggested because Prdx1 is phosphorylated by Cdc2 during mitosis, resulting in an inhibition of Prdx1 peroxidase activity 13 . The mechanism underlying the slower proliferation of cells lacking Prdx1 is unknown but might reflect chronic oxidative stress. Other studies have shown that overexpressing peroxiredoxins increases cellular resistance to oxidative stress 14, 15 . Consistent with this, Prdx1 2/2 MEFs showed signifi- letters to nature cantly lower clonogenic survival in response to oxidant treatment ( Fig. 3e) and had greater concentrations of peroxide-induced cellular ROS (Fig. 3f) as compared with wild-type MEFs. We also examined cellular oxidative DNA damage by fluorescence staining of MEFs with fluorescein isothiocyanate (FITC)-conjugated avidin, which detects 8-oxoguanine (8-oxoG) 16 -a principal oxidative DNA lesion that can cause base mispairing and mutations. Prdx1 2/2 MEFs had significantly greater basal and peroxideinduced concentrations of 8-oxoguanine (Fig. 3g) than did wildtype MEFs. The staining was predominantly nuclear (Fig. 3h) and was significantly blocked by preincubating avidin-FITC with an 8-oxoG-containing oligonucleotide but not a non-oxidized oligonucleotide (Fig. 3g, h) . Collectively, these observations suggest that loss of Prdx1 increases the susceptibility of non-erythroid tissues to cancer by causing a heightened sensitivity to oxidants and an increase in both cellular ROS and oxidative DNA damage. The loss of Prdx1 protein expression in tumours from Prdx1 þ/2 mice is consistent with this mechanism.
Natural killer cells are lymphocyte effector cells of the innate immune system that may be important in protecting against tumour development 17 , and Pdrx1 has been identified as an erythrocyte cytosolic protein, NK enhancing factor A (NKEF-A), that stimulates NK activity 10 . We therefore examined NK cells of Prdx1 mutant mice as another mechanism that might contribute to tumorigenesis. Partially purified splenic NK cells from Prdx1
mice showed a reproducible and statistically significant decrease in lytic activity towards YAC-1 target cells (Fig. 3i) 
NK1.1 þ cells was observed in all Prdx1
2/2 mice tested (Fig. 3j) . A two-to threefold increase in the frequency of a subset of NK cells expressing the inhibitory receptor Ly49A (NK1.1 þ Ly49A þ cells) 18 was also observed in Prdx1 2/2 mice (Fig. 3j) . The frequency of NK cells expressing the activation receptor Ly49D 18 was more variable, but in three out of four experiments we observed reduced (,80% of wild-type) frequencies of NK1.1 þ Ly49D þ cells in Prdx1 2/2 mice (data not shown). We confirmed previous observations that addition of erythrocytes stimulates the cytotoxic activity of NK cells 10 , and observed a significant decrease in red blood cell (RBC) NK-enhancing activity when erythrocytes from Prdx1 2/2 mice were added to NK cells from wild-type mice ( Table 2 ). The residual NK-enhancing activity of RBCs lacking Prdx1 could be due to the presence of Prdx2 (also known as NKEF-B), although only Prdx1 shows NK-enhancing activity as a purified protein 19 . Notably, wild-type RBCs had little stimulatory effect on the minimal cytotoxic activity of Prdx1 2/2 NK cells ( Table 2 ), suggesting that Prdx1 may be required in both NK cells and non-immune cells for optimal NK function in vivo.
Our results implicate Prdx1 directly in protecting against ROS in red cells and in tumour suppression in ageing mice. Physiological roles for peroxiredoxins in both areas have been postulated 20 , but direct proof has been lacking. The main antioxidant defences in red cells were thought to be the glutathione peroxidase and catalase enzyme systems, which use nicotinamide adenine dinucleotide phosphate (NADPH) generated by the hexose monophosphate shunt through glucose 6-phosphate dehydrogenase as the electron donor and glutathione as the direct ROS scavenger. But an absence of either catalase or glutathione peroxidase-1 (ref. 21) does not lead to haemolysis in mice, whereas deficiency of haematopoietic mitochondrial superoxide dismutase causes only mild haemolysis that does not impair survival 22 . By contrast, loss of Prdx1 causes severe fatal haemolytic anaemia but only in ageing mice, which suggests that other red cell antioxidant defences initially compensate for the lack of Prdx1 but that deficiency in these pathways acquired with age leads to haemolysis. Notably, Prdx1 þ/2 mice with haemolysis still express Prdx1 in bone marrow or red cells but have about 50% of the Prdx1 concentrations of wild-type mice in these tissues (data not shown), suggesting that large amounts of Prdx1 are necessary for normal red cell survival in older mice.
Similarly, although a role for ROS in carcinogenesis has long been postulated, several mutant mouse strains with deficiencies in antioxidant pathways show an increase in spontaneous cancer development only in response to carcinogens 23, 24 . Our results argue that Prdx1 has a direct role in tumour suppression in older mice by eliminating ROS and preventing oxidative DNA damage. Prdx1 and other peroxiredoxins are overexpressed in some human cancers 25 , suggesting that tumours that arise through other mechanisms may benefit from increased amounts of peroxiredoxins. Our findings further suggest that Prdx1 regulates NK cell development and cytotoxic function through both cell-autonomous and cell-nonautonomous mechanisms, and that defective NK cell activity may predispose Prdx1 mutant mice to cancer through a loss of tumour surveillance.
Prdx1 can also inhibit the function of both c-Abl 12 and c-Myc 26 , two proteins whose constitutively active forms cause several haematopoietic neoplasms including lymphoma and histiocytic sarcoma. We did not investigate Myc levels or function in Prdx1 2/2 tumours, but several tumours showed an increase in protein tyrosine phosphorylation relative to normal tissues. We did not detect direct tyrosine phosphorylation of c-Abl in these tumours by immunoprecipitation and western blot analysis (data not shown), but this may in part reflect redundancy among the peroxiredoxins, because Prdx3 can also inhibit Abl in transfection experiments (C.A.N. and R.A.V., unpublished data). Establishing the precise mechanisms underlying the cancer susceptibility of Prdx1 mutant mice will require further studies. These mice should be a valuable tool for understanding the role of antioxidant pathways in ageing, carcinogenesis and other pathophysiological processes.
Note added in proof: Mice deficient in Peroxiredoxin 2 were recently reported to develop nonfatal haemolytic anemia 31 . A
Methods

Generation of Prdx1 2/2 mice
An AvrI fragment from a bacterial artificial clone spanning the Prdx1 locus was cloned into the vector pCWKO. A targeting vector was generated by transposon-mediated mutagenesis 27 , in which a transposon carrying unique restriction sites was inserted into exon III of Prdx1 (Supplementary Fig. 1 ). We then cloned a PGK-neo expression cassette, consisting of the neomycin resistance gene fused to PGK promoter, into this vector. ES cells (line Tc-1) were electroporated with this construct and selected for resistance to G418 and gancyclovir. Southern blot analysis showed that 52 of 129 doubly resistant clones analysed were correctly targeted. We injected three independent clones into blastocysts from B6 mice and crossed the resulting chimeras back to B6 mice to generate Prdx1 þ/2 mice.
Erythrocyte survival, ROS, protein oxidation and unstable haemoglobin
Erythrocytes from individual healthy wild-type and anaemic Prdx1 2/2 mice were labelled in vivo with biotin-X-N-hydroxysuccinimide ester (Calbiochem) as described 28 , 10 7 labelled erythrocytes were injected intravenously into wild-type recipient mice, and the kinetics of the disappearance of biotin-labelled cells from circulation was measured by flow cytometric staining with phycoerythrin-conjugated streptavidin.
To measure ROS, we loaded erythrocytes with 10 mM 2 0 ,7 0 -dichlorodihydrofluorescein diacetate (DCF, Sigma) and analysed intracellular fluorescence intensity by flow cytometry 5 and 20) and a 4-h chromium release assay was done as described 30 as described 29 . Protein oxidation in erythroid tissues from anaemic Prdx1 2/2 and agematched wild-type mice was determined by incubating lysates in the presence or absence of 2,4-dinitrophenylhydrazine (DNPH) to derivatize oxidized carbonyl groups to 2,4-dinitrophenylhydrazone 22 , followed by western blotting with an antibody against DNP (Invitrogen). To measure unstable haemoglobin, we lysed erythrocytes from anaemic Prdx1 2/2 (n ¼ 3) and age-matched wild-type control (n ¼ 4) mice with distilled water and precipitated the membranes by adding 150 mM NaCl. The supernatant was analysed for haemoglobin concentration before and after the addition of 17% isopropanol by spectrophotometric determination of absorbance at 540-580 nm.
NK cells:
Cell cycle, clonogenic survival, ROS and 8-oxoG analysis MEFs established from two independent pairs of wild-type and Prdx1 2/2 littermates were plated in duplicate cultures and the cell number was determined daily. We analysed the DNA content by flow cytometric analysis using propidium iodide staining of unsynchronized cells collected on day 4. To assess clonogenic survival in response to oxidative stress, MEFs were treated with hydrogen peroxide for 30 min and plated in triplicate, and the colonies were counted 7 d later.
To measure ROS concentrations, MEFs were stimulated with peroxide for 10 min in serum-and phenol-red-free medium, incubated with 50 mM DCF for 10 min, and then washed and analysed with a Axiovert S200 microscope (Zeiss) and an Ocra CCD (chargecoupled device) camera (Hamamatsu). At least 15 individual cell images were acquired per condition, background levels were subtracted, and the mean total cellular fluorescence intensity was quantified by OpenLab 3.1.2 software (Improvision). Results are expressed as the mean fluorescence intensity normalized to that of wild-type cells treated with 1,000 mM peroxide.
To measure 8-oxoG, MEFs growing on fibronectin-coated coverslips were treated with peroxide in serum-free and phenol-red-free medium for 2 h at 37 8C, fixed in absolute methanol (220 8C, 20 min) and permeabilized with 0.1% Triton X-100 (room temperature, 15 min). After nonspecific binding sites were blocked, the cells were stained with 15 mg ml 21 FITC-conjugated avidin (Sigma) for 1 h at 37 8C. To verify specificity of the detection of 8-oxoG, avidin-FITC was preincubated with an eightfold excess of either a 23-base oligodeoxynucleotide (Sigma) containing a single 8-oxodeoxyguanosine residue or a control unoxidized oligonucleotide. We measured and quantified the normalized the mean cellular fluorescence intensity as described above.
NK cell cytolytic activity and cell-surface antigen expression
Splenocytes from Prdx1 2/2 (n ¼ 15) and age-matched wild-type (n ¼ 15) young mice were enriched for NK cells by centrifugation over Lympholyte-M (Cedarlane Laboratories) and passage over a nylon wool column. We determined cytotoxic activity in duplicate at four different effector to target ratios in a 4-h chromium-release assay by using 51 Cr-labelled YAC-1 cells as a target as described 
